| Catalog Number | KRP324 |
| Alias | 类胰岛素生长因子结合蛋白2, Insulin-like growth factor-binding protein 2 , IBP-2, IGF-binding protein 2, IGFBP-2, mIGFBP-2, Igfbp-2, Insulin-like growth factor-binding protein 2, IBP-2, |
| Size | 20ug, 50ug, 100ug, 200ug, 1mg |
| Product Description | Mouse Igfbp2(35-305 aa) |
| Molecular Name | Igfbp2 |
| Product Introduction | 类胰岛素生长因子结合蛋白2调节细胞生长和分化的因子。。 |
| Molecular Weight | 35 kDa |
| Expression System | HEK293F Cells |
| Species | Mouse |
| Concentration | 联系销售经理获得最新批次的浓度 |
| Purity | ≥95% |
| SDS-PAGE | |
| Purification | Affinity Purification |
| Uniprot ID | P47877 |
| Storage Condition | Store the product under sterile conditions after opening at -80℃ for 12 months. Store the lyophilized powder at -20℃. Avoid repeated freeze-thaw cycles. |
| Formulation | Supplied in PBS |
| Shipping Condition | This product is shipped on ice packs or dry ice. |
| Background | Multifunctional protein that plays a critical role in regulating the availability of IGFs such as IGF1 and IGF2 to their receptors and thereby regulates IGF-mediated cellular processes including proliferation, differentiation, and apoptosis in a cell-type specific manner (PubMed:18276763). Functions coordinately with receptor protein tyrosine phosphatase beta/PTPRB and the IGF1 receptor to regulate IGF1-mediated signaling by stimulating the phosphorylation of PTEN leading to its inactivation and AKT1 activation (PubMed:26773517). Plays a positive role in cell migration via interaction with integrin alpha5/ITGA5 through an RGD motif. Additionally, interaction with ITGA5/ITGB1 enhances the adhesion of endothelial progenitor cells to endothelial cells. Upon mitochondrial damage, facilitates apoptosis with ITGA5 of podocytes, and then activates the phosphorylation of focal adhesion kinase (FAK)-mediated mitochondrial injury. {ECO:0000250|UniProtKB:P18065, ECO:0000269|PubMed:18276763, ECO:0000269|PubMed:26773517}. |
| Endotoxin | < 0.1 EU per ug |
| Biological Activity | Measured by its ability to inhibit the biological activity of IGF-I orIGF-II on MCF‑7 human breast cancer cells. The ED50 forthis effect is 0.125‑0.5 µg/mL in the presence of 30 ng/mL rmIGFII. |
| Product Declaration | 该产品仅供科研使用，不可直接用于人体或注射。 |
销售微信
官方公众号
0
